Incyte Invested Capital vs Enterprise Value Analysis

INCY Stock

USD 52.35 0.47 0.89%

Incyte financial indicator trend analysis is infinitely more than just investigating Incyte recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Incyte is a good investment. Please check the relationship between Incyte Invested Capital and its Enterprise Value accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Invested Capital vs Enterprise Value

Invested Capital vs Enterprise Value Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Incyte Invested Capital account and Enterprise Value. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Incyte's Invested Capital and Enterprise Value is 0.11. Overlapping area represents the amount of variation of Invested Capital that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Incyte, assuming nothing else is changed. The correlation between historical values of Incyte's Invested Capital and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Invested Capital of Incyte are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Invested Capital i.e., Incyte's Invested Capital and Enterprise Value go up and down completely randomly.

Correlation Coefficient

0.11

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Incyte. There are two different methods for calculating Incyte invested capital: operating approach and financing approach. Understanding Incyte invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Incyte theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Incyte debt, but would also pocket its cash. Enterprise Value is more accurate representation of Incyte value than its market capitalization because it takes into account all of Incyte existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Most indicators from Incyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 229.8 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.30 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.2B	2.6B	2.8B	2.9B
Cost Of Revenue	151.0M	207.0M	255M	267.8M

Total Operating Expenses Cost Of Revenue

Incyte fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Non Currrent Assets Other	Net Receivables	Property Plant And Equipment Gross	Intangible Assets	Short Term Investments	Other Assets	Long Term Debt
Total Assets		-0.58	0.35	0.8	0.99	0.98	-0.98	0.64	0.79	0.99	0.99	0.99	0.52	-0.25	0.99	0.93	0.87	1.0	-0.39	0.85	0.99	0.99	0.39	0.92	0.88	-0.67
Short Long Term Debt Total	-0.58		0.14	-0.17	-0.67	-0.62	0.7	-0.5	-0.49	-0.56	-0.6	-0.56	-0.12	0.87	-0.61	-0.59	-0.15	-0.57	0.69	-0.35	-0.62	-0.6	-0.39	-0.54	-0.44	0.98
Other Current Liab	0.35	0.14		0.63	0.3	0.36	-0.31	0.14	0.68	0.37	0.31	0.37	0.45	0.34	0.3	0.3	0.55	0.37	0.26	0.12	0.33	0.28	0.29	0.26	0.33	0.09
Total Current Liabilities	0.8	-0.17	0.63		0.74	0.76	-0.71	0.47	0.69	0.78	0.8	0.79	0.51	0.18	0.75	0.7	0.93	0.79	0.22	0.69	0.78	0.78	0.4	0.74	0.72	-0.24
Total Stockholder Equity	0.99	-0.67	0.3	0.74		0.98	-0.99	0.66	0.78	0.98	0.98	0.99	0.48	-0.35	0.98	0.93	0.81	0.99	-0.46	0.83	0.99	0.99	0.39	0.92	0.87	-0.74
Property Plant And Equipment Net	0.98	-0.62	0.36	0.76	0.98		-0.96	0.59	0.84	0.96	0.98	0.96	0.55	-0.3	0.99	0.94	0.83	0.97	-0.43	0.76	0.99	0.98	0.42	0.89	0.84	-0.71
Net Debt	-0.98	0.7	-0.31	-0.71	-0.99	-0.96		-0.66	-0.8	-0.98	-0.96	-0.98	-0.48	0.41	-0.97	-0.92	-0.78	-0.98	0.5	-0.81	-0.97	-0.97	-0.38	-0.88	-0.86	0.78
Retained Earnings	0.64	-0.5	0.14	0.47	0.66	0.59	-0.66		0.39	0.65	0.63	0.63	-0.25	-0.47	0.62	0.34	0.43	0.63	-0.37	0.73	0.62	0.68	-0.13	0.45	0.85	-0.45
Accounts Payable	0.79	-0.49	0.68	0.69	0.78	0.84	-0.8	0.39		0.78	0.77	0.78	0.61	-0.22	0.81	0.79	0.71	0.79	-0.29	0.43	0.8	0.74	0.47	0.65	0.68	-0.57
Cash	0.99	-0.56	0.37	0.78	0.98	0.96	-0.98	0.65	0.78		0.97	1.0	0.49	-0.25	0.97	0.91	0.87	1.0	-0.4	0.87	0.97	0.98	0.32	0.89	0.89	-0.64
Non Current Assets Total	0.99	-0.6	0.31	0.8	0.98	0.98	-0.96	0.63	0.77	0.97		0.97	0.5	-0.25	0.98	0.93	0.86	0.98	-0.38	0.83	0.99	0.99	0.44	0.92	0.87	-0.68
Cash And Short Term Investments	0.99	-0.56	0.37	0.79	0.99	0.96	-0.98	0.63	0.78	1.0	0.97		0.51	-0.23	0.97	0.93	0.88	1.0	-0.39	0.87	0.97	0.98	0.35	0.92	0.88	-0.65
Common Stock Shares Outstanding	0.52	-0.12	0.45	0.51	0.48	0.55	-0.48	-0.25	0.61	0.49	0.5	0.51		0.24	0.52	0.72	0.6	0.52	0.01	0.19	0.52	0.45	0.64	0.6	0.19	-0.28
Non Current Liabilities Total	-0.25	0.87	0.34	0.18	-0.35	-0.3	0.41	-0.47	-0.22	-0.25	-0.25	-0.23	0.24		-0.31	-0.21	0.21	-0.25	0.68	-0.14	-0.29	-0.28	0.04	-0.15	-0.27	0.8
Other Current Assets	0.99	-0.61	0.3	0.75	0.98	0.99	-0.97	0.62	0.81	0.97	0.98	0.97	0.52	-0.31		0.93	0.84	0.98	-0.45	0.82	0.98	0.98	0.36	0.89	0.88	-0.7
Other Stockholder Equity	0.93	-0.59	0.3	0.7	0.93	0.94	-0.92	0.34	0.79	0.91	0.93	0.93	0.72	-0.21	0.93		0.81	0.93	-0.4	0.68	0.94	0.91	0.55	0.93	0.68	-0.71
Total Liab	0.87	-0.15	0.55	0.93	0.81	0.83	-0.78	0.43	0.71	0.87	0.86	0.88	0.6	0.21	0.84	0.81		0.87	0.01	0.8	0.84	0.85	0.36	0.82	0.78	-0.27
Total Current Assets	1.0	-0.57	0.37	0.79	0.99	0.97	-0.98	0.63	0.79	1.0	0.98	1.0	0.52	-0.25	0.98	0.93	0.87		-0.4	0.86	0.98	0.99	0.36	0.92	0.88	-0.66
Short Term Debt	-0.39	0.69	0.26	0.22	-0.46	-0.43	0.5	-0.37	-0.29	-0.4	-0.38	-0.39	0.01	0.68	-0.45	-0.4	0.01	-0.4		-0.31	-0.42	-0.41	-0.03	-0.31	-0.35	0.71
Non Currrent Assets Other	0.85	-0.35	0.12	0.69	0.83	0.76	-0.81	0.73	0.43	0.87	0.83	0.87	0.19	-0.14	0.82	0.68	0.8	0.86	-0.31		0.82	0.88	0.02	0.77	0.87	-0.42
Net Receivables	0.99	-0.62	0.33	0.78	0.99	0.99	-0.97	0.62	0.8	0.97	0.99	0.97	0.52	-0.29	0.98	0.94	0.84	0.98	-0.42	0.82		0.99	0.39	0.91	0.87	-0.7
Property Plant And Equipment Gross	0.99	-0.6	0.28	0.78	0.99	0.98	-0.97	0.68	0.74	0.98	0.99	0.98	0.45	-0.28	0.98	0.91	0.85	0.99	-0.41	0.88	0.99		0.33	0.91	0.9	-0.67
Intangible Assets	0.39	-0.39	0.29	0.4	0.39	0.42	-0.38	-0.13	0.47	0.32	0.44	0.35	0.64	0.04	0.36	0.55	0.36	0.36	-0.03	0.02	0.39	0.33		0.51	0.02	-0.44
Short Term Investments	0.92	-0.54	0.26	0.74	0.92	0.89	-0.88	0.45	0.65	0.89	0.92	0.92	0.6	-0.15	0.89	0.93	0.82	0.92	-0.31	0.77	0.91	0.91	0.51		0.7	-0.63
Other Assets	0.88	-0.44	0.33	0.72	0.87	0.84	-0.86	0.85	0.68	0.89	0.87	0.88	0.19	-0.27	0.88	0.68	0.78	0.88	-0.35	0.87	0.87	0.9	0.02	0.7		-0.48
Long Term Debt	-0.67	0.98	0.09	-0.24	-0.74	-0.71	0.78	-0.45	-0.57	-0.64	-0.68	-0.65	-0.28	0.8	-0.7	-0.71	-0.27	-0.66	0.71	-0.42	-0.7	-0.67	-0.44	-0.63	-0.48

Click cells to compare fundamentals

Incyte Account Relationship Matchups

Incyte fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4B	3.6B	4.9B	5.8B	6.8B	7.1B
Short Long Term Debt Total	50.9M	34.9M	34.3M	44.6M	38.3M	36.4M
Other Current Liab	76.1M	86.2M	82.8M	469.7M	111.7M	70.6M
Total Current Liabilities	500.5M	648.8M	885.1M	1.2B	1.2B	1.3B
Total Stockholder Equity	2.6B	2.6B	3.8B	4.4B	5.2B	5.4B
Property Plant And Equipment Net	406.6M	588.1M	751.5M	765.6M	777.0M	815.9M
Net Debt	(1.8B)	(1.5B)	(2.0B)	(2.9B)	(3.2B)	(3.0B)
Retained Earnings	(1.4B)	(1.7B)	(777.9M)	(437.2M)	160.4M	168.4M
Accounts Payable	83.6M	98.8M	172.1M	277.5M	109.6M	115.1M
Cash	1.8B	1.5B	2.1B	3.0B	3.2B	3.4B
Non Current Assets Total	889.7M	1.1B	1.7B	1.6B	2.1B	2.2B
Cash And Short Term Investments	2.1B	1.8B	2.3B	3.2B	3.7B	3.8B
Common Stock Shares Outstanding	217.7M	218.1M	222.1M	224.0M	225.9M	130.7M
Liabilities And Stockholders Equity	3.4B	3.6B	4.9B	5.8B	6.8B	7.1B
Non Current Liabilities Total	327.9M	300.9M	278.3M	254.3M	351.9M	340.4M
Other Current Assets	94.2M	103.3M	165.3M	167.0M	182.8M	192.0M
Other Stockholder Equity	4.0B	4.4B	4.6B	4.8B	5.0B	5.3B
Total Liab	828.3M	949.7M	1.2B	1.5B	1.6B	1.7B
Total Current Assets	2.5B	2.4B	3.2B	4.2B	4.6B	4.9B
Short Term Debt	28.3M	15.0M	13.2M	11.4M	9.1M	8.7M
Non Currrent Assets Other	55.6M	62.8M	68.1M	106.1M	260.9M	274.0M
Net Receivables	308.8M	482.0M	616.3M	644.9M	743.6M	780.7M
Property Plant And Equipment Gross	406.6M	559.6M	751.5M	765.6M	1.0B	1.1B
Accumulated Other Comprehensive Income	(15.5M)	(15.4M)	(19.5M)	15.1M	13.1M	13.8M
Intangible Assets	193.8M	172.3M	150.8M	129.2M	123.5M	74.2M
Short Term Investments	284.9M	288.4M	290.8M	287.5M	442.7M	464.8M
Other Assets	55.6M	25.1M	467.5M	564.0M	648.6M	681.1M
Common Stock Total Equity	216K	219K	221K	223K	256.5K	154K
Common Stock	216K	219K	221K	223K	224K	157.9K
Property Plant Equipment	377.6M	559.6M	723.9M	739.3M	850.2M	892.7M
Current Deferred Revenue	312.4M	448.9M	617.0M	457.9M	1.0B	1.1B
Other Liab	271.2M	266M	244M	269.6M	310.0M	156.9M
Inventory	16.5M	36.0M	56.9M	121.0M	63.0M	66.1M
Net Tangible Assets	2.2B	2.3B	3.5B	4.1B	4.7B	4.9B
Retained Earnings Total Equity	(1.4B)	(1.7B)	(777.9M)	(437.2M)	(502.8M)	(527.9M)
Capital Surpluse	4.0B	4.4B	4.6B	4.8B	5.5B	3.4B
Non Current Liabilities Other	315.0M	318.5M	309.0M	313.8M	322.7M	278.6M

Incyte Investors Sentiment

The influence of Incyte's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Incyte. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Incyte's public news can be used to forecast risks associated with an investment in Incyte. The trend in average sentiment can be used to explain how an investor holding Incyte can time the market purely based on public headlines and social activities around Incyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Incyte's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Incyte's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Incyte's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Incyte.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Incyte in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Incyte's short interest history, or implied volatility extrapolated from Incyte options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:

How To Invest In Incyte

Details

Is Incyte Stock a good investment?

Details

What is Incyte's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.

	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

6.324

Earnings Share

2.65

Revenue Per Share

16.526

Quarterly Revenue Growth

0.093

Return On Assets

0.0646

The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Incyte Invested Capital vs Enterprise Value Analysis

Invested Capital vs Enterprise Value

Invested Capital vs Enterprise Value Correlation Analysis

Correlation Coefficient

Invested Capital

Enterprise Value

Incyte fundamental ratios Correlations

Incyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Incyte fundamental ratios Accounts

Incyte Investors Sentiment

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Incyte Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets

Net Debt	- 0.99	Total Stockholder Equity
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Assets
Property Plant And Equipment Gross	- 0.97	Net Debt